Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-02-2023 | Cerebral Sinus Venous Thrombosis | Case report

Azd-1222/immune globulin/methylprednisolone

Ischaemic stroke and cerebral venous sagittal sinus thrombosis and lack of efficacy: 3 case reports

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Siddig A, et al. AstraZeneca COVID-19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series. Clinical Case Reports 10: No. 7, Jul 2022. Available from: URL: http://doi.org/10.1002/ccr3.6017 Siddig A, et al. AstraZeneca COVID-19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series. Clinical Case Reports 10: No. 7, Jul 2022. Available from: URL: http://​doi.​org/​10.​1002/​ccr3.​6017
Metadata
Title
Azd-1222/immune globulin/methylprednisolone
Ischaemic stroke and cerebral venous sagittal sinus thrombosis and lack of efficacy: 3 case reports
Publication date
01-02-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-33042-0

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Levodopa

Case report

Iopamidol

Case report

Blinatumomab

Case report

Paracetamol